`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 1 of 11 PagelD #: 13619
`
`EXHIBIT 15
`EXHIBIT 15
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 2 of 11 PageID #: 13620
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`
`
`
`C.A. No. 22-252-MSG
`
`CONTAINS INFORMATION
`MODERNA DESIGNATED HIGHLY
`CONFIDENTIAL – OUTSIDE
`COUNSEL EYES ONLY
`
`
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GMBH
`
`
`
`Plaintiffs,
`
`
`
`MODERNA, INC. and MODERNATX,
`INC.,
`
`
`
`
`v.
`
`
`
`
`
`Defendants.
`
`PLAINTIFFS’ INITIAL INFRINGEMENT CONTENTIONS
`
`Pursuant to the Court’s Scheduling Order (D.I. 72) and Paragraph 4(c) of the Court’s
`
`Default Standard for Discovery, Including Discovery of Electronically Stored Information,
`
`Plaintiffs Arbutus Biopharma Corporation (“Arbutus”) and Genevant Sciences GmbH
`
`(“Genevant”) disclose their initial infringement contentions regarding U.S. Patent Nos. 8,058,069
`
`(“the ’069 patent”); 8,492,359 (“the ’359 patent”); 8,822,668 (“the ’668 patent”); 9,364,435 (“the
`
`’435 patent”); 9,504,651 (“the ’651 patent”); and 11,141,378 (“the ’378 patent”) to Defendants
`
`Moderna, Inc. and ModernaTX, Inc. (collectively, “Moderna”).
`
`Plaintiffs’ initial infringement contentions are based on the information currently available
`
`to, and known by, Plaintiffs. Fact discovery is ongoing, and Plaintiffs have not yet obtained any
`
`deposition testimony from Moderna. The Court has not yet construed any of the asserted claims
`
`of the patents-in-suit. The Court has set a schedule pursuant to which the parties will identify
`
`terms for construction, provide proposed constructions, cite evidence supportive of those
`
`constructions, confer to narrow the disputes before the Court, and then submit, through briefing
`
`and oral presentations, their arguments to the Court. The Court will then construe the disputed
`
`1
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 3 of 11 PageID #: 13621
`
`
`
`their infringement contentions as the pre-trial phase of the litigation proceeds and as additional
`
`information comes to light. Plaintiffs specifically reserve the right to supplement these
`
`infringement contentions in view of future production of documents, the Court’s issuance of a
`
`claim construction order, and expert opinions and testimony.
`
`These appended claim charts are provided without prejudice to Plaintiffs’ right to introduce
`
`expert opinions and demonstratives as expert discovery progresses, and to produce and introduce
`
`at trial all evidence, whenever discovered, relating to the proof of currently known and
`
`subsequently discovered facts. In addition, the division of each claim into individual limitations
`
`below is for convenience only and is without prejudice to Plaintiffs’ right to argue for a different
`
`
`
`
`
`/s/ Karen E. Keller
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`Nathan R. Hoeschen (No. 6232)
`SHAW KELLER LLP
`I.M. Pei Building
`1105 North Market Street, 12th Floor
`Wilmington, DE 19801
`(302) 298-0700
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`nhoeschen@shawkeller.com
`Attorneys for Plaintiffs
`
`division at a later date.
`
`
`
`
`
`
`OF COUNSEL:
`David I. Berl
`Adam D. Harber
`Thomas S. Fletcher
`Shaun P. Mahaffy
`Jessica Palmer Ryen
`Anthony H. Sheh
`Lydia B. Cash
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue SW
`Washington, DC 20024
`(202) 434-5000
`Attorneys for Plaintiff Genevant
`Sciences GmbH
`
`Daralyn J. Durie
`Shaelyn K. Dawson
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, CA 94105-2482
`(415) 268-6080
`
`
`4
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 4 of 11 PageID #: 13622
`
`Kira A. Davis
`MORRISON & FOERSTER LLP
`707 Wilshire Boulevard
`Los Angeles, CA 90017-3543
`(213) 892-5200
`
`David N. Tan
`MORRISON & FOERSTER LLP
`2100 L Street, NW, Suite 900
`Washington, DC 20037
`Attorneys for Plaintiff Arbutus
`Biopharma Corporation
`
`Dated: April 24, 2023
`
`
`
`5
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 5 of 11 PageID #: 13623
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 5 of 11 PagelD #: 13623
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 6 of 11 PageID #: 13624
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 6 of 11 PagelD #: 13624
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 7 of 11 PageID #: 13625
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 7 of 11 PagelD #: 13625
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 8 of 11 PageID #: 13626
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 8 of 11 PagelD #: 13626
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 9 of 11 PageID #: 13627
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 9 of 11 PagelD #: 13627
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 10 of 11 PageID #: 13628
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 10 of 11 PagelD #: 13628
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 195-21 Filed 01/16/24 Page 11 of 11 PageID #: 13629
`
`
`
`CERTIFICATE OF SERVICE
`
`I, Karen E. Keller, hereby certify that on April 24, 2023, this document was served on the
`
`persons listed below in the manner indicated:
`
`
`
`BY EMAIL:
`Jack B. Blumenfeld
`Brian P. Egan
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@morrisnichols.com
`began@morrisnichols.com
`
`James F. Hurst
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`(312) 862-2000
`james.hurst@kirkland.com
`
`Alina Afinogenova
`KIRKLAND & ELLIS LLP
`200 Clarendon Street
`Boston, MA 02116
`(617) 385-7500
`alina.afinogenova@kirkland.com
`
`
`
`Patricia A. Carson, Ph.D.
`Jeanna M. Wacker
`Mark C. McLennan
`Nancy Kaye Horstman
`KIRKLAND & ELLIS LLP
`601 Lexington Avenue
`New York, NY 10022
`(212) 446-4800
`patricia.carson@kirkland.com
`jeanna.wacker@kirkland.com
`mark.mclennan@kirkland.com
`kaye.horstman@kirkland.com
`
`Yan-Xin Li
`KIRKLAND & ELLIS LLP
`555 California Street, 27th Floor
`San Francisco, CA 94104
`(415) 439-1400
`yanxin.li@kirkland.com
`
`
`
`
`
`/s/ Karen E. Keller
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`Nathan R. Hoeschen (No. 6232)
`SHAW KELLER LLP
`I.M. Pei Building
`1105 North Market Street, 12th Floor
`Wilmington, DE 19801
`(302) 298-0700
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`nhoeschen@shawkeller.com
`Attorneys for Plaintiffs
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`